Rubi Laboratories, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-01.
Rubi Laboratories, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 1, 2025. The filing reports $7.50M sold. Its industry group is Manufacturing. It names Neeka Mashouf (Executive Officer, Director), Leila Mashouf (Executive Officer, Director), Rohini Finch (Director) (SEC Form D, December 1, 2025).
Is this your company?
Sell to companies like Rubi Laboratories, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Rubi Laboratories, Inc.
Free to see. No signup.
More on the people and the money behind Rubi Laboratories, Inc., from the filings we hold.
Manufacturing raises by companies based in California, filed within 90 days of this one, largest first.
Get an email when Rubi Laboratories, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Rubi Laboratories, Inc. raises, hires or launches. No email unless you switch it on.
Watch Rubi Laboratories, Inc. →Get the full cited report on Rubi Laboratories, Inc.
What the filing shows about Rubi Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rubi Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Rubi Laboratories, Inc.'s address as 1501 Harbor Bay Parkway, Suite 200, Alameda, CA 94502.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Rubi Laboratories, Inc. See pricing
Rubi Laboratories, Inc. is a registered filer with the SEC (CIK 1898277) and has filed since 2023-03-01. 3 filings are on record, the latest on 2025-12-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Rubi Laboratories, Inc.'s Form D of 2025-12-01 names Neeka Mashouf, Leila Mashouf, Rohini Finch and 1 more as its officers, directors or promoters.
Its new offerings report $25.66M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 365 filings in Manufacturing, totalled by week. The dot is this raise, $7.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Neeka Mashouf is named as Executive Officer and Director on the Form D that Rubi Laboratories, Inc. filed with the SEC on 1 December 2025, one of 4 people that filing names.
Leila Mashouf is named as Executive Officer and Director on the Form D that Rubi Laboratories, Inc. filed with the SEC on 1 December 2025, one of 4 people that filing names.
Rohini Finch is named as Director on the Form D that Rubi Laboratories, Inc. filed with the SEC on 1 December 2025, one of 4 people that filing names.
Daria Hosseinyoun is named as Director on the Form D that Rubi Laboratories, Inc. filed with the SEC on 1 December 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-12-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Rubi Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rubi Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rubi Laboratories, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Rubi Laboratories, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Rubi Laboratories, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Rubi Laboratories, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Manufacturing raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/rubi-laboratories-inc-form-d-25000001